ReviewClinicoEconomics and outcomes research : CEOR2025

Sensitivity of Cost-Effectiveness to Inclusion of Adverse Drug Events: A Scoping Review of Economic Models of Pharmacological Interventions for Diabetes, Diabetic Retinopathy, and Diabetic Macular Edema.

Mari Pesonen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.